Screener
Travere Therapeutics, Inc. TVTX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Assets | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Stockholders' Equity: | ||
| Preferred stock $0.0001 par value; 20,000,000 shares authorized; no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock $0.0001 par value; 200,000,000 shares authorized; 92,403,744, and 90,922,868 issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 9 | 9 |
| Additional paid-in capital | 1,609,596 | 1,588,721 |
| Accumulated deficit | (1,509,815) | (1,472,713) |
| Accumulated other comprehensive loss | (1,062) | (1,189) |
| Total stockholders' equity | 98,728 | 114,828 |
| Total liabilities and stockholders' equity | $555,188 | $605,191 |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s total liabilities & equity?
- Travere Therapeutics, Inc. (TVTX) reported total liabilities & equity of $555.19M in Q1 2026.
- How has Travere Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Travere Therapeutics, Inc.'s total liabilities & equity increased by 1.2% year-over-year, from $548.8M to $555.19M.
- What is the long-term trend for Travere Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s total liabilities & equity has grown at a -0.1% compound annual growth rate (CAGR), from $607.44M to $605.19M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Travere Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude